We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Actavis Facility in Florida Hit for Inadequate Microbial Controls
Actavis Facility in Florida Hit for Inadequate Microbial Controls
Actavis Laboratories did not conduct adequate investigations when it found potentially harmful bacteria in some of its drug products and didn’t follow its written procedures in other quality-related areas, an FDA investigator observed during an inspection of the company’s drug manufacturing plant in Davie, Fla.